Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation

por Abdallah N, Nagasaka M, Abdulfatah E, Shi D, Wozniak AJ, Sukari A
Publicado 2018

Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer

por Azar I, Alkassis S, Fukui J, Alsawah F, Fedak K, Al Hallak MN, Sukari A, Nagasaka M
Publicado 2021

A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors

por Nagasaka M, Abdallah N, Crosby M, Thummala N, Patel D, Wozniak AJ, Gadgeel S, Abrams J, Sukari A
Publicado 2019